If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
This report was created for strategic planners, international marketing executives and export managers whose primary concern is the world market for sulfonamides. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. I have developed a methodology, based on macroeconomic and trade models, to estimate the market for sulfonamides for those firms serving the world via exports and foreign direct investment. It does so for the current year based on a variety of key historical indicators and econometric models.
In what follows, this report begins by summarizing the world market for sulfonamides exports. The total level of exports on a worldwide basis is based on a model that aggregates across over 150 key country markets and projects these to the current year. From there, each country represents a percent of the world market. This market is served from a number of competitive countries of origin. Based on supply-side dynamics, market shares by country of origin are then calculated across each country market. These shares lead to a volume of export values for each country and are aggregated to regional and world totals. In doing so, we are able to obtain maximum likelihood estimates of both the value of each supplier and the destinations (countries served by the supplier country). From these figures, world rankings are calculated. In this way, all the figures provided in this report are forecasts that can be combined with internal information for strategic planning purposes.
Table Of Contents:
1 METHODOLOGY & EXECUTIVE SUMMARY 71.1 Our Approach 71.2 The World Market: Sulfonamides Export Supplies in 2016 131.3 The World Market: Sulfonamides by Destination in 2016 162 AFRICA: EXPORT SUPPLIES OF SULFONAMIDES 182.1 Executive Summary 182.2 Egypt 202.3 Kenya 212.4 South Africa 213 ASIA: EXPORT SUPPLIES OF SULFONAMIDES 223.1 Executive Summary 223.2 China 263.3 Hong Kong 273.4 India 283.5 Indonesia 293.6 Japan 303.7 Malaysia 303.8 Singapore 313.9 South Korea 323.10 Taiwan 333.11 Thailand 334 EUROPE: EXPORT SUPPLIES OF SULFONAMIDES 344.1 Executive Summary 344.2 Austria 384.3 Belgium 394.4 Croatia 404.5 Cyprus 404.6 Czech Republic 404.7 Denmark 414.8 Estonia 414.9 Finland 414.10 France 424.11 Germany 434.12 Greece 444.13 Hungary 444.14 Ireland 454.15 Italy 464.16 Malta 474.17 Poland 474.18 Portugal 484.19 Romania 484.20 Russia 484.21 Slovakia 494.22 Slovenia 494.23 Spain 504.24 Sweden 514.25 the Netherlands 524.26 Ukraine 535 LATIN AMERICA: EXPORT SUPPLIES OF SULFONAMIDES 545.1 Executive Summary 545.2 Argentina 575.3 Brazil 585.4 Chile 585.5 Colombia 585.6 Mexico 585.7 Panama 595.8 Uruguay 595.9 Venezuela 596 NORTH AMERICA & THE CARIBBEAN: EXPORT SUPPLIES OF SULFONAMIDES 606.1 Executive Summary 606.2 Canada 646.3 the United States 657 OCEANA: EXPORT SUPPLIES OF SULFONAMIDES 667.1 Executive Summary 667.2 Australia 687.3 New Zealand 698 THE MIDDLE EAST: EXPORT SUPPLIES OF SULFONAMIDES 708.1 Executive Summary 708.2 Israel 748.3 Turkey 749 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 759.1 Disclaimers & Safe Harbor 759.2 ICON Group International, Inc. User Agreement Provisions 76